A comparison of arrived dose to the heart in the treatment of breast cancer in different modes of proton radiation by proton therapy using Monte Carlo simulation

javidi, hassan; ahmadiganjeh, zahra

doi:10.18502/ssu.v26i12.659

Volume 26, Issue 12 (Mar 2018) JSSU 2018, 26(12): 1019-1026 | Back to browse issues page

‎ 10.18502/ssu.v26i12.659

Mendeley

Zotero

RefWorks

javidi H, ahmadiganjeh Z. A comparison of arrived dose to the heart in the treatment of breast cancer in different modes of proton radiation by proton therapy using Monte Carlo simulation. JSSU 2018; 26 (12) :1019-1026
URL: http://jssu.ssu.ac.ir/article-1-4623-en.html

A comparison of arrived dose to the heart in the treatment of breast cancer in different modes of proton radiation by proton therapy using Monte Carlo simulation

Hassan Javidi

, Zahra Ahmadiganjeh ^*

Abstract: (3760 Views)

Introdution: Today, the Advantages of radiation therapy by charged particles is indicated for the treatment of cancerous. During the passing of proton beam in the body tissues, secondary particles produce, which penetrate to the body healthy tissues and cause damage. The aim of this research was calculating the Spread out Bragg Peak for covering the breast cancer and investigating arrived dose to the different parts of the heart during the treatment process.
Methods: In this simulation study, a spherical tumor with a diameter of 1 cm considered in right breast tissue in MIRD phantom and then irradiated by proton of right and front sides of the body. Simulations are performed using the MCNPX code.
Results: The Spread out Brag Peak calculated to cover the breast cancer in two cases of radiation. In the radiation of front and right, the deposited Dose due to The Proton Particle in tumor are 4.25 nGy and 4.12 nGy, respectively. The dose due to the protons and secondary particles in different parts of the heart calculated and compared for two modes of radiation. Energy Ranges of neutrons was about 55 MeV and for electrons and photons was less than 20 MeV. Although, the dose due to the secondary particles was very low in comparison of protons dose.
Conclusion: In proton therapy, a large portion of the dose is evacuated in the tumor. Proton radiation of the front in comparison of the right leads to the more dose deposit in the tumor and heart.

Keywords: Proton therapy, Breast cancer, Heart, Spread out Bragg Peak, Secondary particles dose, MCNPX

Full-Text [PDF 836 kb] (1251 Downloads)

Type of Study: Original article | Subject: Medical Physics
Received: 2018/07/1 | Accepted: 2018/12/29 | Published: 2019/04/16

References

1. 1- Symonds RP, Foweraker K. Principles of chemotherapy and radiotherapy. Curr Obstet Gynaecol. 2006; 16(2): 100-6.

2. 2- Symonds RP. Recent advances in radiotherapy. BMJ 2001; 323(7321): 1107-10.

3. 3- Wilson RR. Radiological use of fast protons radiology. Radiol 1946; 47(5): 487-91.

4. 4- Lawrence JH, Tobias C, ABorn JL, McCombs R, Roberts JE, Anger HO, et al. Pituitary Irradiation with High Energy Proton Beams: a Preliminary Report. Canc Res 1958; 18(2):121-34.

5. 5- Jia SB, Romano F, Giuseppe AP, Cuttone G, Hadizadeh MH, Mowlavi AA, et al. designing a range modulator wheel to spread-out the Bragg peak for a passive proton therapy facility. Nucl Instrum Methods Phys Res A 2016; 806: 101-8.

6. 6- Sridhar T, Paul Symonds R. Principles of chemotherapy and radiotherapy. Obstet Gynaecol Reprod Med. 2009; 19 : 61-67.

7. 7- Luo L, Cuaron J, Braunstein L, Gillespie E, Kahn A, McCormick B, et al. Early outcomes of breast cancer patients treated with post-mastectomy uniform scanning proton therapy. Radiother Oncol 2019; 132: 250-6.

8. 8- Francesco Tommasino F, Fellin F, Lorentini S, Farace P. Impact of dose engine algorithm in pencil beam scanning proton therapy for breast cancer. Phys Med 2018; 50: 7-12.

9. 9- Gustavo R. Sarria G, Ángel Berenguer Francés M, Linares Galiana I. Enhancing radiotherapy effect in breast cancer with nanoparticles: A review, Phys Med 2019; 24: 65-7.

10. 10- MacDonald SM, Patel SA, Hickey S, Specht M, Isakoff SJ, Gadd M, et al. Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial. Int J Radiat Oncol Biol Phys 2013; 86(3): 484-90.

11. 11- Krämer M, Jäkel O, Haberer T, Kraft G, Schardt D, Weber U. Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization. Phys Med Biol 2000; 45(11): 3299.

12. 12- Durante M, Loeffler JS. Charged particles in radiation oncology. Nat Rev Clin Oncol 2010; 7(1): 37-43.

13. 13- Dosanjh M, Jones B, Meyer R. ENLIGHT and other EU-funded projects in hadron therapy. Br J Radiol 2010; 83(994): 811-13.

14. 14- Doyen J, Doyen J, Falk AT, Floquet V, Hérault J, Hannoun-Lévi JM, et al. Proton beams in cancer treatments: Clinical outcomes and dosimetric comparisons with photon therapy. Cancer Treat Rev 2016; 43: 104-12.

15. 15- Mohan R, Grosshans D. Proton therapy – Present and future. Adv Drug Delivery Rev 2017; 109: 26-44.

16. 16- Paganetti H, proton therapy physics, Boston: CRC Press 2018.

17. 17- Janni JF. Proton Range-Energy Tables and 1KeV - 10 GeV: Energy Loss and Range and Path Length and Time-of-Flight and Straggling and Multiple Scattering and Nuclear Interaction Probability.Part I. Atomic Data and Nuclear Data Tables 1982; 27: 147-349.

18. 18- Paganetti H, Nuclear interactions in proton therapy: dose and relative biological effect distributions originating from primary and secondary particles, Phys Med Biol 2002; 47: 747-764.

19. 19- Jia SB, Hadizadeh MH, Mowlavi AA, Loushab M. Evaluation of energy deposition and secondary particle production in proton therapy of brain using a slab head phantom. Rep Pract Oncol Radiother 2014; 19(6): 376-84.

20. 20- Pelowitz D. MCNPX User’s manual, LA CP 07 1473. Ver. 2.6.0. USA: Los Alamos National Laboratory. 2008

22.